Terms: = Colorectal cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
31 results:
1. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
Eren T
ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
[TBL] [Abstract] [Full Text] [Related]
3. Clinical impact of pretreatment albumin-globulin ratio in patients with colorectal cancer: A meta-analysis.
Ma JY; Liu G; Pan LZ; Hu M; Zhu ZZ
Medicine (Baltimore); 2022 May; 101(20):e29190. PubMed ID: 35608420
[TBL] [Abstract] [Full Text] [Related]
4. BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination.
Parker C; Chambers AC; Flanagan DJ; Ho JWY; Collard TJ; Ngo G; Baird DM; Timms P; Morgan RG; Sansom OJ; Williams AC
DNA Repair (Amst); 2022 Jul; 115():103331. PubMed ID: 35468497
[TBL] [Abstract] [Full Text] [Related]
5. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
6. The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study.
Huang X; Cui J; Li X; Liu C; Sun J; Yue J
World J Surg Oncol; 2021 Oct; 19(1):297. PubMed ID: 34645481
[TBL] [Abstract] [Full Text] [Related]
7. Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk.
Tian T; Bi H; Zhang D; Liu Y; Sun H; Jia C; Zheng T; Huang H; Fu J; Zhu L; Zhao Y
Cancer Med; 2021 Jul; 10(14):4964-4976. PubMed ID: 34145793
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
[TBL] [Abstract] [Full Text] [Related]
9. Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome.
van den Berg I; van de Weerd S; van Klaveren D; Coebergh van den Braak RRJ; van Krieken JHJM; Koopman M; Roodhart JML; Medema JP; IJzermans JNM
Eur J Surg Oncol; 2021 Aug; 47(8):2060-2068. PubMed ID: 33745794
[TBL] [Abstract] [Full Text] [Related]
10. [The development of a general drug resistance score model based on MIC
Chen HX; Xu L; Li J; Guo Z; Ao L
Yi Chuan; 2020 Jun; 42(6):577-585. PubMed ID: 32694116
[TBL] [Abstract] [Full Text] [Related]
11. BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.
Collard TJ; Fallatah HM; Greenhough A; Paraskeva C; Williams AC
Int J Oncol; 2020 May; 56(5):1304-1313. PubMed ID: 32319612
[TBL] [Abstract] [Full Text] [Related]
12. The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
Legge DN; Chambers AC; Parker CT; Timms P; Collard TJ; Williams AC
Carcinogenesis; 2020 May; 41(3):249-256. PubMed ID: 31930327
[TBL] [Abstract] [Full Text] [Related]
13. Magnitude of the Age-Advancement Effect of Comorbidities in colorectal cancer prognosis.
Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
[TBL] [Abstract] [Full Text] [Related]
14. Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis.
Yamashita K; Oka S; Tanaka S; Nagata S; Hiraga Y; Kuwai T; Furudoi A; Tamura T; Kunihiro M; Okanobu H; Nakadoi K; Kanao H; Higashiyama M; Kuraoka K; Shimamoto F; Chayama K
J Gastroenterol; 2019 Oct; 54(10):897-906. PubMed ID: 31104172
[TBL] [Abstract] [Full Text] [Related]
15. Metastasis directed therapy for liver and lung metastases from colorectal cancer-A population-based study.
Boysen AK; Spindler KL; Høyer M; Mortensen FV; Christensen TD; Farkas DK; Ording AG
Int J Cancer; 2018 Dec; 143(12):3218-3226. PubMed ID: 29923284
[TBL] [Abstract] [Full Text] [Related]
16. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract] [Full Text] [Related]
17. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Impact of Changes in Adipose Tissue Areas after Colectomy in colorectal cancer Patients.
Choe EK; Park KJ; Ryoo SB; Moon SH; Oh HK; Han EC
J Korean Med Sci; 2016 Oct; 31(10):1571-8. PubMed ID: 27550485
[TBL] [Abstract] [Full Text] [Related]
19. Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.
Gao C; Fang L; Li JT; Zhao HC
World J Gastroenterol; 2016 Feb; 22(8):2576-84. PubMed ID: 26937145
[TBL] [Abstract] [Full Text] [Related]
20. CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis.
Zhao Y; Peng J; Zhang E; Jiang N; Li J; Zhang Q; Zhang X; Niu Y
Oncotarget; 2016 Mar; 7(9):10023-36. PubMed ID: 26840260
[TBL] [Abstract] [Full Text] [Related]
[Next]
